Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Ford

Showing results (251-260 of 451) with videos related to

Pageof 46
Sort By:
Alimentary Pharmacology & Therapeutics|June 12, 2023
Letter: determining priorities for patients with faecal incontinence and irritable bowel syndrome-authors' replyVivek C Goodoory, Cho E Ng, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2022
Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition. Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
BMJ (Clinical Research Ed.)|May 22, 2014
Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trialsAlexander C Ford, David Forman, Richard H Hunt, et al.
Alimentary Pharmacology & Therapeutics|March 14, 2023
Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndromeVivek C Goodoory, Cho E Ng, Christopher J Black, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2023
Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel SyndromeVivek C Goodoory, Ashok K Tuteja, Christopher J Black, et al.
Gastroenterology|January 17, 2025
Eradication Therapy to Prevent Gastric Cancer in Helicobacterpylori-Positive Individuals: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational StudiesAlexander C Ford, Yuhong Yuan, Jin Young Park, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 28, 2025
Management of irritable bowel syndrome in primary careSarah L Alderson, Christopher J Black, Alexander C Ford, et al.
Neurogastroenterology and Motility|September 2, 2021
Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel diseaseKeeley M Fairbrass, Christian P Selinger, David J Gracie, et al.
Gastroenterology|January 26, 2018
Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel DiseaseDavid J Gracie, Elspeth A Guthrie, P John Hamlin, et al.
The Lancet. Gastroenterology & Hepatology|April 21, 2025
Efficacy of gut-brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysisMais Khasawneh, Marjan Mokhtare, Paul Moayyedi, et al.
Pageof 46

Showing results (251-260 of 451) with videos related to

Sort By:
Pageof 46
Alimentary Pharmacology & Therapeutics|June 12, 2023
Letter: determining priorities for patients with faecal incontinence and irritable bowel syndrome-authors' replyVivek C Goodoory, Cho E Ng, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2022
Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition. Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
BMJ (Clinical Research Ed.)|May 22, 2014
Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trialsAlexander C Ford, David Forman, Richard H Hunt, et al.
Alimentary Pharmacology & Therapeutics|March 14, 2023
Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndromeVivek C Goodoory, Cho E Ng, Christopher J Black, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2023
Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel SyndromeVivek C Goodoory, Ashok K Tuteja, Christopher J Black, et al.
Gastroenterology|January 17, 2025
Eradication Therapy to Prevent Gastric Cancer in Helicobacterpylori-Positive Individuals: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational StudiesAlexander C Ford, Yuhong Yuan, Jin Young Park, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 28, 2025
Management of irritable bowel syndrome in primary careSarah L Alderson, Christopher J Black, Alexander C Ford, et al.
Neurogastroenterology and Motility|September 2, 2021
Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel diseaseKeeley M Fairbrass, Christian P Selinger, David J Gracie, et al.
Gastroenterology|January 26, 2018
Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel DiseaseDavid J Gracie, Elspeth A Guthrie, P John Hamlin, et al.
The Lancet. Gastroenterology & Hepatology|April 21, 2025
Efficacy of gut-brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysisMais Khasawneh, Marjan Mokhtare, Paul Moayyedi, et al.
Pageof 46